Oxford Global Conferences are proud to present the 3rd Annual Microbiology & Infectious Diseases Asia Congress, taking place on 11-12 October 2016 in Singapore. The event is a unique opportunity for over 300 experts working in molecular diagnostics, microbiology, genome sequencing technologies and infectious diseases to hear essential insights into the latest developments and research results that shape the current landscape of the industry.
300 delegates from world renowned academic institutions, hospitals, global pharmaceutical organisations and leading biotechnology companies.
36 presentations and case studies focusing on the key developments in clinical microbiology, microbial genomics, molecular diagnostics and infectious diseases.
4 interactive streams:
- Detection Technologies and Molecular Diagnostics
- Novel Insights Into Clinical Microbiology
- Microbial Genomics And Genome Sequencing
- Infectious Diseases
The Asia Pacific represents an evolving market for both microbiology and infectious disease. This growth can be accredited to the increased accessibility of advanced detection and genome sequencing technologies. Experts have highlighted the importance of microbiology and molecular testing to help Asian countries eliminate infectious diseases such as dengue, malaria and scarlet fever by 2030.
On day one our esteemed speakers will discuss cutting edge detection technologies and updates in applying molecular diagnostic technologies for microbiology research. Presentations will also focus on the key areas of clinical microbiology, covering advances in the fight against antibiotic resistance, TB and key challenges in vaccine development and virology.
On day two delegates will have the opportunity to explore the advances in microbial genomics and genome sequencing. Our highly distinguished speakers will discuss the extent to which next-generation sequencing technologies are being used in microbiology and infectious disease as well as innovations and future trends in both metagenomics and metabolomics. Presentations will also embrace recent breakthroughs in emerging and re-emerging infectious diseases, such as the recent ZIKA outbreak and the continuous spread of scarlet fever, influenza and dengue in Asia.
This year, our 3rd Annual Microbiology and Infectious Disease Asia Congress will be co-located for the first time with both our 6th Annual Next Generation Sequencing Asia Congress and our 4th Annual Single Cell Analysis Asia Congress.
These events will focus on a number of hot topics and key areas within the NGS and Single Cell field, including:
- DNA sequencing, mass parallel sequencing, genome editing, single cell analysis and NGS data analysis methods on sample preparation
- Single cell isolation, imaging technologies, genomics, PCR analysis, transcriptomics, and proteomics.
- CRISPR and gene re-arrangements and genome anomalies.
300 delegates from world renowned academic institutions, hospitals, global pharmaceutical organisations and leading biotechnology companies.
36 presentations and case studies focusing on the key developments in clinical microbiology, microbial genomics, molecular diagnostics and infectious diseases.
4 interactive streams:
- Detection Technologies and Molecular Diagnostics
- Novel Insights Into Clinical Microbiology
- Microbial Genomics And Genome Sequencing
- Infectious Diseases
The Asia Pacific represents an evolving market for both microbiology and infectious disease. This growth can be accredited to the increased accessibility of advanced detection and genome sequencing technologies. Experts have highlighted the importance of microbiology and molecular testing to help Asian countries eliminate infectious diseases such as dengue, malaria and scarlet fever by 2030.
On day one our esteemed speakers will discuss cutting edge detection technologies and updates in applying molecular diagnostic technologies for microbiology research. Presentations will also focus on the key areas of clinical microbiology, covering advances in the fight against antibiotic resistance, TB and key challenges in vaccine development and virology.
On day two delegates will have the opportunity to explore the advances in microbial genomics and genome sequencing. Our highly distinguished speakers will discuss the extent to which next-generation sequencing technologies are being used in microbiology and infectious disease as well as innovations and future trends in both metagenomics and metabolomics. Presentations will also embrace recent breakthroughs in emerging and re-emerging infectious diseases, such as the recent ZIKA outbreak and the continuous spread of scarlet fever, influenza and dengue in Asia.
This year, our 3rd Annual Microbiology and Infectious Disease Asia Congress will be co-located for the first time with both our 6th Annual Next Generation Sequencing Asia Congress and our 4th Annual Single Cell Analysis Asia Congress.
These events will focus on a number of hot topics and key areas within the NGS and Single Cell field, including:
- DNA sequencing, mass parallel sequencing, genome editing, single cell analysis and NGS data analysis methods on sample preparation
- Single cell isolation, imaging technologies, genomics, PCR analysis, transcriptomics, and proteomics.
- CRISPR and gene re-arrangements and genome anomalies.
